Low-dose cisplatin administration to septic mice improves bacterial clearance and programs peritoneal macrophage polarization to M1 phenotype
Low-dose cisplatin administration to septic mice improves bacterial clearance and programs peritoneal macrophage polarization to M1 phenotype
复制标题
对脓毒症小鼠给予低剂量顺铂可改善细菌清除并将腹膜巨噬细胞极化至 M1 表型。
DOI:
10.1111/2049-632x.12189
复制
发表时间:
2014-11-01
影响因子:
3.3
通讯作者:
Wei, Yuquan
中科院分区:
文献类型:
--
作者:
Li, Yanyan;Wang, Zhenling;Wei, Yuquan
Sepsis is a systemic inflammatory response to infection, and early responses of macrophages are vital in controlling the infected microorganisms. We used a cecal ligation and puncture (CLP) model of sepsis to determine the role of cisplatin (0.1, 0.5 and 1mgkg(-1)) with respect to peritoneal macrophages, controlling peritoneal/blood bacterial infection, and systemic inflammation. We found that mice which received low-dose (0.1 and 0.5mgkg(-1)) i.p. cisplatin had lower mortality rate and improved clinical scores compared with mice in normal saline-treated group, and the level of IL-6 and TNF- was significantly reduced after cisplatin administration in peritoneal fluid of mice underwent CLP. Although cisplatin had no directly bactericidal ability, the numbers of bacteria in peritoneal and blood were significantly reduced at 24 and 72h after the onset of CLP. Besides, in vivo phagocytosis and killing assay showed that the ability of macrophage derived from peritoneum was significantly increased with cisplatin treatment (5, 10, and 15M) for both gram-positive (Enterococcus faecalis) and gram-negative (Escherichia coli) bacteria. This was associated with the macrophage phenotype polarization from CD11b(+)F4/80(high)CD206(-) to CD11b(+)F4/80(low)CD206(-) M1 group. These findings underscore the importance of low-dose cisplatin in the treatment of sepsis.